PATENT CLAIM ANALYSIS

Application Number: 16007653
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "451000"]

Abstract:
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Claim (Index 55):
The dosage form of  claim 39 , wherein the anti-inflammatory agent is selected from the group consisting of ibuprofen, diclofenac, naproxen, benoxaprofen, flurbiprofen, fenoprofen, flubufen, ketoprofen, indoprofen, piroprofen, carprofen, oxaprozin, pramoprofen, muroprofen, trioxaprofen, suprofen, aminoprofen, tiaprofenic acid, fluprofen, bucloxic acid, indomethacin, sulindac, tolmetin, zomepirac, tiopinac, zidometacin, acemetacin, fentiazac, clidanac, oxpinac, mefenamic acid, meclofenamic acid, flufenamic acid, niflumic acid tolfenamic acid, diflurisal, flufenisal, piroxicam, sudoxicam, isoxicam, celecoxib, meloxicam, nabumetone.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 94.0
- Lexical Diversity: 1.17857
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12914054', '15019695', '14612483', '15019609', '15019531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8359460247084809
- 35 USC 102 Novelty (BERT): 0.5465407433176993
- Combined Prediction Score: 0.8070054965694028
- Mean Citation Score: 458.683948
- Max Citation Score: 461.66776
- Similarity Product: 278.4556846021748

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test